Biotech And Drug Industry Interest Fueling The Centrifuge Revolution

Centrifuge Revolution (The Scientist, Vol:10, #6, p. 18-19, March 18, 1996) Increased interest by the biotechnology and biopharmaceutical industries in powerful instruments capable of separating the smallest of molecules has put a new spin on an old laboratory standard-the centrifuge. Small centrifuges (microfuges) and larger tabletop instruments critical for cell separations and DNA applications can be found on benches in practically every molecular biology laboratory. The larger ultracentrifu

Written byHolly Ahern
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

Centrifuge Revolution (The Scientist, Vol:10, #6, p. 18-19, March 18, 1996)

Increased interest by the biotechnology and biopharmaceutical industries in powerful instruments capable of separating the smallest of molecules has put a new spin on an old laboratory standard-the centrifuge. Small centrifuges (microfuges) and larger tabletop instruments critical for cell separations and DNA applications can be found on benches in practically every molecular biology laboratory. The larger ultracentrifuges are now used by scientists to perform analytical and highly quantitative analyses of biological molecules in solution.

Centrifuge
'WHISPER QUIET': Savant's SFA13K miucrocentrifuge, left, and SFR13K refrigerated microcentrifuge respond to user's need for operation at lower noise levels.
Along with these powerful machines, specially designed centrifuge tubes and containers have made their way to the laboratory products market. These supplies can withstand centrifugal forces hundreds of thousands of times the force of gravity.

The theory that explains how particles move through a centrifugal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies